Immix Biopharma (IMMX)'s 30-day implied volatility (IV30) was 81.8% at the close on October 20, 2026, down from 86.3% the day before, against a 52-week range of 59.3% to 138.4%. Its 20-day historical volatility was 79.2%.
Data as of October 20, 2026.